Mercer Street Global Opportunity Fund Takes 6.2% Stake in Biodexa Pharma

TL;DR

**Mercer Street just bought 6.2% of Biodexa Pharma, a bullish sign!**

AI Summary

Mercer Street Global Opportunity Fund, LLC reported on January 8, 2024, that as of December 21, 2023, they beneficially own 1,500,000 Ordinary Shares of Biodexa Pharmaceuticals Plc, representing 6.2% of the company's outstanding shares. This significant stake makes Mercer Street a major shareholder, indicating their belief in Biodexa's future prospects. For investors, this matters because a large institutional investment can signal confidence in the company's valuation and strategic direction, potentially attracting more investor interest.

Why It Matters

This filing reveals a significant institutional investor, Mercer Street Global Opportunity Fund, has taken a substantial position in Biodexa Pharmaceuticals, signaling potential confidence in the company's future.

Risk Assessment

Risk Level: low — This filing indicates a new institutional investor, which is generally a positive signal and does not inherently increase risk.

Analyst Insight

A smart investor would research Mercer Street Global Opportunity Fund's investment thesis and consider if Biodexa Pharmaceuticals Plc aligns with their own investment strategy, given this new institutional backing.

Key Numbers

• 1,500,000 — Ordinary Shares (Total number of Biodexa Pharmaceuticals Plc Ordinary Shares beneficially owned by Mercer Street Global Opportunity Fund, LLC.)
• 6.2% — Ownership Percentage (The percentage of Biodexa Pharmaceuticals Plc's Ordinary Shares beneficially owned by Mercer Street Global Opportunity Fund, LLC.)
• 400 — Ordinary Shares per ADS (Each American Depositary Share (ADS) of Biodexa Pharmaceuticals Plc represents 400 Ordinary Shares.)

Key Players & Entities

• Mercer Street Global Opportunity Fund, LLC (company) — reporting person, beneficial owner of shares
• Biodexa Pharmaceuticals Plc (company) — subject company, issuer of securities
• 1,500,000 (dollar_amount) — number of Ordinary Shares beneficially owned
• 6.2% (dollar_amount) — percentage of class beneficially owned
• December 21, 2023 (dollar_amount) — date of event requiring the filing

Forward-Looking Statements

• Biodexa Pharmaceuticals Plc may see increased investor confidence due to Mercer Street's significant stake. (Biodexa Pharmaceuticals Plc) — medium confidence, target: Q1 2024

FAQ

Filing Documents

• mercer_13g.htm (SC 13G) — 39KB
• 0001079973-24-000041.txt ( ) — 41KB

Ownership

Item 4. Ownership. (a)–(c) The information required by Items 4(a)-(c) is set forth in Rows (5)-(9) and Row (11) of the cover page and is incorporated herein by reference. The percentages used in this Schedule 13G are calculated based on 1,047,806,522 Ordinary Shares outstanding, as reported by the Issuer in the Report of Foreign Private Issuer of Form 6-K filed with the Securities and Exchange Commission on December 21, 2023, after giving effect to the consummation of the offering described therein, and assumes the exercise of the reported warrants held by the Reporting Person, subject to the 9.99% Blocker (as defined below). Jonathan Juchno may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the securities disclosed as owned herein. To the extent Mr. Juchno is deemed to beneficially own such shares, Mr. Juchno disclaims beneficial ownership of these securities for all other purposes. Pursuant to the terms of certain warrants held by the Reporting Person, the Reporting Person cannot exercise such warrants to the extent the Reporting Person would beneficially own, after such exercise, more than 9.99% of the outstanding Ordinary Shares (the “9.99% Blocker”). The percentage set forth on Row (11) and the number of Ordinary Shares set forth on rows (6), (8) and (9) of the cover page for the Reporting Person give effect to the 9.99% Blocker. Consequently, at this time, the Reporting Person is not able to exercise all the warrants held by the Reporting Person due to the 9.99% Blocker. Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following Item 6. Not applicable. Item 7. Identification and Classification

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. By: MERCER STREET GLOBAL OPPORTUNITY FUND, LLC January 2, 2024 By: /s/ Jonathan Juchno Jonathan Juchno, Authorized representative

View Full Filing

View this SC 13G filing on SEC EDGAR